Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 4,526–4,550 of 7,816 matching trials · page 182 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease NCT03082755 Gabapentin Enacarbil; Placebo Oral Tablet Runs in: United States · 1 site |
PHASE4 other |
RECRUITING | 156 | University of Texas at Austin OTHER |
2022-05-18 |
|
Going Down Memory Lane: A Technological Intervention NCT04131374 Reminiscence Therapy |
NA other |
UNKNOWN | 10 | University of Calgary OTHER |
2022-05-18 |
|
Melatonin in Alzheimer's Disease: Effect on Disease Progression and Epileptiform Activity. NCT04522960 MEG+hdEEG+MRI Runs in: Belgium · 1 site |
NA other |
UNKNOWN | 60 | Universitair Ziekenhuis Brussel OTHER |
2022-05-18 |
|
Neuroinflammation and Alzheimer's Pathology in POCD NCT05378659 Montreal Cognitive Assessment; Stroop Test; 4AT Delirium; Grooved P... Runs in: United States · 1 site |
NA other |
UNKNOWN | 120 | University of Tennessee Graduate School of Medicine OTHER |
2022-05-18 |
|
Evaluation of the Contribution of Regular Cognitive Exercises to Treatment in Patients With Alzheimer's Disease NCT03954613 Ebicomb Runs in: Turkey (Türkiye) · 1 site |
PHASE4 other |
UNKNOWN | 198 | Neutec Ar-Ge San ve Tic A.Ş INDUSTRY |
2022-05-17 |
|
Investigating the Impact of Alzheimer's Disease Diagnostics in British Columbia NCT05002699 Alzheimer's disease CSF biomarkers Runs in: Canada · 4 sites |
NA other |
UNKNOWN | 120 | University of British Columbia OTHER |
2022-05-17 |
|
Development and Evaluation of Computerized Olfactory Training Program for Cognitive Decline in Early Alzheimer's Disease NCT05122598 COT; Sham Runs in: United States · 3 sites |
PHASE2 other |
UNKNOWN | 200 | Evon Medics LLC INDUSTRY |
2022-05-17 |
|
Levetiracetam for Alzheimer's Disease-Associated Network Hyperexcitability NCT02002819 levetiracetam Runs in: United States · 2 sites |
PHASE2 other |
COMPLETED | 34 | University of Minnesota OTHER |
2022-05-16 |
|
Treatment in Occupational Therapy With Significant Activities to Improve Quality of Life NCT05359978 To with significance activities Runs in: Spain · 1 site |
NA other |
COMPLETED | 240 | Universidad de Burgos OTHER |
2022-05-16 |
|
Alzheimer's Disease Imaging With PET/MRI - Beta-amyloid NCT02343757 PET/MRI Runs in: United States · 1 site |
NA other |
TERMINATED | 4 | University Hospitals Cleveland Medical Center OTHER |
2022-05-12 |
|
Imaging Biomarkers of Mild Traumatic Brain Injury: a Longitudinal Cohort Study NCT02868684 Runs in: China · 1 site |
NA other |
COMPLETED | 200 | First Affiliated Hospital Xi'an Jiaotong University OTHER |
2022-05-12 |
|
Mortality Risk Prediction Tool in Hospitalized Dementia Patients NCT05371782 |
NA other |
COMPLETED | 298,576 | University of Toronto OTHER |
2022-05-12 |
|
The Mechanism Study of Diabetic Pancreatic Amyloid Deposition on Cognitive Dysfunction in Alzheimer's Disease NCT05372458 Runs in: China · 1 site |
NA other |
UNKNOWN | 400 | Huashan Hospital OTHER |
2022-05-12 |
|
Renew NCP-5 for the Treatment of Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild Dementia of the Alzheimer's Type NCT03721705 Renew NCP-5 Runs in: Ireland; Singapore; United States · 12 sites |
PHASE3 other |
COMPLETED | 190 | Renew Research, LLC OTHER |
2022-05-11 |
|
Different Premedication in Pediatric Patients NCT04266340 dexmedetomidine; midazolam; midazolam; Saline Runs in: China · 1 site |
NA other |
COMPLETED | 320 | Eye & ENT Hospital of Fudan University OTHER |
2022-05-11 |
|
Notification of Donors With Positive Microbiology Markers NCT01050881 Runs in: United Kingdom · 1 site |
NA other |
COMPLETED | 217 | NHS Blood and Transplant OTHER_GOV |
2022-05-10 |
|
Nicotine Treatment of Cognitive Decline in Down Syndrome NCT01778946 Low Dose Nicotine (7mg); Moderate Dose Nicotine (14mg) Runs in: United States · 1 site |
PHASE1|PHASE2 other |
COMPLETED | 7 | Vanderbilt University Medical Center OTHER |
2022-05-10 |
|
In-Home Technology for Dementia Caregivers NCT03828383 In-home technology; Limited in-home technology Runs in: United States · 5 sites |
NA other |
COMPLETED | 78 | University of California, Berkeley OTHER |
2022-05-10 |
|
In-Home Technology for Caregivers of People With Dementia and Mild Cognitive Impairment NCT04206670 In-Home Technology System and Questionnaires; Waiting Control In-Ho... Runs in: United States · 1 site |
NA other |
COMPLETED | 216 | University of California, Berkeley OTHER |
2022-05-10 |
|
Oxytocin, Alcohol Craving, and Intimate Partner Aggression NCT03046836 Oxytocin; Placebo Runs in: United States · 1 site |
PHASE2 other |
COMPLETED | 200 | Medical University of South Carolina OTHER |
2022-05-09 |
|
Fall Detection and Prevention for Memory Care Through Real-time Artificial Intelligence Applied to Video NCT03685240 SafelyYou Fall Prevention System Runs in: United States · 1 site |
NA other |
UNKNOWN | 460 | SafelyYou INDUSTRY |
2022-05-09 |
|
A Study to Assess the Safety of GRF6021 Infusions in Subjects With Parkinson's Disease and Cognitive Impairment NCT03713957 GRF6021; Placebo Runs in: Australia; France; United States · 29 sites |
PHASE2 other |
COMPLETED | 79 | Alkahest, Inc. INDUSTRY |
2022-05-09 |
|
A Comprehensive Fall Prevention System for Memory Care: Final Feasibility and Randomized Controlled Study NCT04478149 SafelyYou; Control |
PHASE2 other |
UNKNOWN | 300 | SafelyYou INDUSTRY |
2022-05-09 |
|
Elucidating the Necessary Active Components of Training NCT05366023 BUD1; BUD2; TDD1; TDD2; CSA10; CSA20; CSA30; CSA40 Runs in: United States · 1 site |
NA other |
UNKNOWN | 280 | Clemson University OTHER |
2022-05-09 |
|
Study Evaluating Lecozotan SR in Mild to Moderate Alzheimer's Disease (AD) NCT00151398 lecozotan SR; Donepezil Runs in: Argentina; Australia; Canada; South Africa; United States · 56 sites |
PHASE2 symptomatic-cholinergic |
COMPLETED | 229 | Wyeth is now a wholly owned subsidiary of Pfizer INDUSTRY |
2022-05-06 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial